Mice in the vehicle control group developed large ASC tumors with 75.5% lung area defined as tumor, while AF-treated mice exhibited significantly lower tumor burden (15.7%; Fig. 4A and B), consistent with previously observed therapeutic response in KL;ASC GEMMs (Talwelkar et al., 2019). This evidence concerns the gene KL and neoplasm.